MABVAX THERAPEUTICS HOLDINGS, INC. 4
4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed May 23, 2017
Insider Transaction Report
Form 4
EISENBERG JEFFREY F
Director
Transactions
- Award
Option to Purchase Common Stock
2017-05-19$1.80/sh+50,000$90,000→ 50,000 totalExercise: $1.80Exp: 2027-05-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option is fully vested and exercisable and was issued pursuant to conditions of the Letter Agreement, dated May 15, 2017, by and between the Company and the lead investor in connection with the Company's public offering completed on May 19, 2017, and filed with the Securities and Exchange Commission on May 22, 2017 as Exhibit A of Exhibit 10.2 of the Company's Quarterly Report on Form 10-Q.